EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19
WHO
The Impact of EXercise TRAining, Physical Activity and Sedentary Lifestyle on Clinical Outcomes in Surviving Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2: Cross-sectional Study
1 other identifier
observational
1,574
1 country
1
Brief Summary
The present study aims to assess the impact of exercise training, physical activity, and sedentary lifestyle on clinical outcomes in surviving patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therefore, this study will evaluate cross-sectionally and through a questionnaire in Portuguese and English on the internet, whether physically active patients have better outcomes for the disease such as shorter hospital stay, lesser symptoms, lesser need for mechanical ventilation, and medications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2020
CompletedFirst Posted
Study publicly available on registry
May 20, 2020
CompletedStudy Start
First participant enrolled
June 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2020
CompletedOctober 22, 2020
May 1, 2020
4 months
May 18, 2020
October 21, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Number of hospitalizations
Number of hospitalizations required due to COVID-19
Up to 6 months after hospital discharge and/or full recovery from the disease (asymptomatic)
Secondary Outcomes (3)
Percentage of symptoms of the disease
Up to 6 months after hospital discharge and/or full recovery from the disease (asymptomatic)
Length of hospital stay
Up to 6 months after hospital discharge and/or full recovery from the disease (asymptomatic)
Percentage of mechanical ventilation
Up to 6 months after hospital discharge and/or full recovery from the disease (asymptomatic)
Study Arms (2)
Physically active
Those who receive regular amounts of physical activity. Those who participate in a minimum of 150 minutes of moderate exercise, or 75 minutes of a more vigorous regimen as recommended by the health organizations. Additionally, a person who spend less time sitting (i.e. watching television, surfing the web, playing video games).
Sedentary
Those who do not receive regular amounts of physical activity. Where physical inactivity is considered the failure to meet the recommendations of the health organizations, stating that an individual should participate in a minimum of 150 minutes of moderate exercise, or 75 minutes of a more vigorous regimen. Sitting about 70-85% of the time (i.e. watching television, surfing the web, playing video games) is also considered a person living a sedentary lifestyle.
Interventions
Clinical, anthropometric, and sociodemographic variables to characterize the sample will be collected using the Google Form. The same tool will be used to collect clinical variables (outcomes), as well as to obtain data on the level of physical activity and sedentary behavior time (predictor variables) prior to SARS-CoV-2 contamination. For this, we will use the International Physical Activity Questionnaire (IPAQ).
Eligibility Criteria
Surviving patients infected with SARS-CoV-2, as confirmed by a reverse transcription-polymerase chain reaction (RT-PCR) test, blood test (serology), and a rapid antibody test in Brazil and worldwide, will be considered eligible for the study. Only those patients fully recovered from the disease and asymptomatic will be included.
You may qualify if:
- Men and women recovered and survivors of the disease
- With or without symptoms
- Patients with disease confirmation by reverse transcription-polymerase chain reaction (RT-PCR) test, blood test (serology), and a rapid antibody test
- With or without the need for hospitalization (nursery, semi-intensive and intensive unit)
- With or without the need for drug treatment
- Presence of any chronic disease such as diabetes, hypertension, coronary artery disease, obesity, metabolic syndrome, cancer, among others
- Literate patients in Portuguese and/or English.
You may not qualify if:
- Illiterate patients with difficulties in filling out the electronic form
- Patients still hospitalized and/or with symptoms of COVID-19
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marcelo Rodrigues dos Santos
São Paulo, São Paulo, 05403-900, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marcelo R Santos, PhD
University of Sao Paulo Medical School
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 18, 2020
First Posted
May 20, 2020
Study Start
June 4, 2020
Primary Completion
October 1, 2020
Study Completion
October 1, 2020
Last Updated
October 22, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- Starting in June 2020. All the data will be available permanently.
- Access Criteria
- Data will be available to other researchers after the end of the study. Data will be available for statistical analyses. The personal data of volunteers will not be identified. The principal investigator will be responsible for requests and criteria for information that will be shared.
All data will be shared publicly through the tool Open Science Framework.